These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1069 related items for PubMed ID: 16343103
1. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma. Kinlaw WB, Scott SM, Maue RA, Memoli VA, Harris RD, Daniels GH, Porter DM, Belloni DR, Spooner ET, Ernesti MM, Noll WW. Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103 [Abstract] [Full Text] [Related]
2. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations. Learoyd DL, Gosnell J, Elston MS, Saurine TJ, Richardson AL, Delbridge LW, Aglen JV, Robinson BG. Clin Endocrinol (Oxf); 2005 Dec; 63(6):636-41. PubMed ID: 16343097 [Abstract] [Full Text] [Related]
3. A large family with hereditary MTC: role of RET genetic analysis in differential diagnosis between MEN 2A and FMTC. Chiefari E, Chiarella R, Crocetti U, Tardio B, Arturi F, Russo D, Trischitta V, Filetti S, Zingrillo M. Horm Metab Res; 2001 Jan; 33(1):52-6. PubMed ID: 11280716 [Abstract] [Full Text] [Related]
4. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal. Prazeres HJ, Rodrigues F, Figueiredo P, Naidenov P, Soares P, Bugalho MJ, Lacerda M, Campos B, Martins TC. Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668 [Abstract] [Full Text] [Related]
5. RET proto-oncogene testing in infants presenting with Hirschsprung disease identifies 2 new multiple endocrine neoplasia 2A kindreds. Fialkowski EA, DeBenedetti MK, Moley JF, Bachrach B. J Pediatr Surg; 2008 Jan; 43(1):188-90. PubMed ID: 18206480 [Abstract] [Full Text] [Related]
6. [Genetic analysis of RET mutations in families with multiple endocrine neoplasia type II in the community of Murcia]. Pomares Gómez FJ, Bernabé Espinosa MJ, Matías-Guiu Guía X, Rodríguez González JM, Soriano Palao J, Sola Pérez J, Carbonell Meseguer P, Parrilla Paricio P, Tébar Massó FJ. Med Clin (Barc); 1999 May 15; 112(17):646-50. PubMed ID: 10374185 [Abstract] [Full Text] [Related]
7. [Analysis of mutations in the RET proto-oncogene in patients with medullary thyroid tumor]. Amosenko FA, Brzhezovskiĭ VZh, Liubchenko LN, Shabanov MA, Kozlova VM, Vanushko VE, Kazubskaia TP, Gar'kavtseva RF, Kalinin VN. Genetika; 2003 Jun 15; 39(6):847-54. PubMed ID: 12884527 [Abstract] [Full Text] [Related]
8. Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation. Milos IN, Frank-Raue K, Wohllk N, Maia AL, Pusiol E, Patocs A, Robledo M, Biarnes J, Barontini M, Links TP, de Groot JW, Dvorakova S, Peczkowska M, Rybicki LA, Sullivan M, Raue F, Zosin I, Eng C, Neumann HP. Endocr Relat Cancer; 2008 Dec 15; 15(4):1035-41. PubMed ID: 18794325 [Abstract] [Full Text] [Related]
9. [Management of multiple endocrine neoplasia syndrome type 2 families in association with rare germline mutations of the RET proto-oncogene]. Fitze G, Saeger HD, Roesner D, Schackert HK. Klin Padiatr; 2004 Dec 15; 216(5):270-6. PubMed ID: 15455293 [Abstract] [Full Text] [Related]
10. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A. Lips CJ, Landsvater RM, Höppener JW, Geerdink RA, Blijham G, van Veen JM, van Gils AP, de Wit MJ, Zewald RA, Berends MJ. N Engl J Med; 1994 Sep 29; 331(13):828-35. PubMed ID: 7915822 [Abstract] [Full Text] [Related]
11. When is prophylactic thyroidectomy indicated for patients with the RET codon 609 mutation? Calva D, O'Dorisio TM, Sue O'Dorisio M, Lal G, Sugg S, Weigel RJ, Howe JR. Ann Surg Oncol; 2009 Aug 29; 16(8):2237-44. PubMed ID: 19472011 [Abstract] [Full Text] [Related]
13. [Neural crest and multiple endocrinopathies]. Pasini A, Michiels FM, Chappuis-Flament S, Geneste O, Rossel M, Fournier L, Feunteun J, Lenoir G, Schuffenecker I, Billaud M. C R Seances Soc Biol Fil; 1996 Aug 29; 190(5-6):557-67. PubMed ID: 9074721 [Abstract] [Full Text] [Related]
14. [C634R mutation of the protooncongene RET and molecular diagnosis in multiple endocrine neoplasia type 2 in a large Moroccan family]. Benazzouz B, Hafidi A, Benkhira S, Chraibi A, Kadiri A, Hilal L. Bull Cancer; 2008 Apr 29; 95(4):457-63. PubMed ID: 18495576 [Abstract] [Full Text] [Related]
15. The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo. Oliveira MN, Hemerly JP, Bastos AU, Tamanaha R, Latini FR, Camacho CP, Impellizzeri A, Maciel RM, Cerutti JM. Thyroid; 2011 Sep 29; 21(9):975-85. PubMed ID: 21834681 [Abstract] [Full Text] [Related]
16. Multiple endocrine neoplasia type 2A in a kindred with C634Y mutation. Jackson MB, Guttenberg M, Hedrick H, Moshang T. Pediatrics; 2005 Sep 29; 116(3):e468-71. PubMed ID: 16099853 [Abstract] [Full Text] [Related]
17. One hundred and seven family members with the rearranged during transfection V804M proto-oncogene mutation presenting with simultaneous medullary and papillary thyroid carcinomas, rare primary hyperparathyroidism, and no pheochromocytomas: is this a new syndrome--MEN 2C? Shifrin AL, Xenachis C, Fay A, Matulewicz TJ, Kuo YH, Vernick JJ. Surgery; 2009 Dec 29; 146(6):998-1005. PubMed ID: 19958926 [Abstract] [Full Text] [Related]
18. [Mutations of ret-proto-oncogene in thyroid medullary carcinoma]. Frank-Raue K, Höppner W, Buhr H, Herfarth C, Ziegler R, Raue F. Dtsch Med Wochenschr; 1997 Feb 07; 122(6):143-9. PubMed ID: 9081799 [Abstract] [Full Text] [Related]
19. [Usefulness of the genetic study in the diagnosis of medullary carcinoma of the thyroid]. Rafecas A, Ribas Y, Villabona C, Viladrich M, Figueras J, Fabregat J, Torras J, Gómez JM, Jaurrieta E. Med Clin (Barc); 1998 Nov 14; 111(16):619-22. PubMed ID: 9881336 [Abstract] [Full Text] [Related]
20. RET proto-oncogene mutations are restricted to codons 634 and 918 in mainland Chinese families with MEN2A and MEN2B. Zhou Y, Zhao Y, Cui B, Gu L, Zhu S, Li J, Liu J, Yin M, Zhao T, Yin Z, Yu C, Chen C, Wang L, Xiao B, Hong J, Zhang Y, Tang Z, Wang S, Li X, Ning G. Clin Endocrinol (Oxf); 2007 Oct 14; 67(4):570-6. PubMed ID: 17573899 [Abstract] [Full Text] [Related] Page: [Next] [New Search]